The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Transfection Reagents And Equipment Market Compare Between 2026 And 2030?
The transfection reagents and equipment market size has experienced rapid growth in recent years. It is expected to expand from $1.74 billion in 2025 to $1.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. The growth observed in the historic period can be attributed to the expansion of molecular biology research activities, increasing use of cell-based assays, growth of recombinant protein production, rising academic and industrial genomics research, and the availability of advanced transfection chemistries.
The transfection reagents and equipment market size is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $2.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period can be linked to the increasing adoption of CRISPR and gene therapy research, a rising demand for scalable transfection platforms, the development of biopharmaceutical pipelines, growing investment in precision medicine, and increased automation in life science laboratories. Significant trends expected in the forecast period include the wider use of high-efficiency transfection reagents, an escalating demand for gene editing-compatible delivery systems, the growing application of non-viral transfection methods, the expansion of automated transfection instruments, and a more concentrated focus on cell-type specific transfection solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Transfection Reagents And Equipment Market Growth?
The increasing global count of cancer patients is anticipated to boost the expansion of the transfection reagents and equipment market. Cancer refers to a collection of illnesses where cells develop irregularly and without control. In cancer research, transfection reagents are frequently employed to insert external genetic material, such as plasmid DNA or RNA molecules, enabling scientists to explore diverse facets of cancer biology, including gene expression analyses, gene silencing, drug screening, and target identification. For instance, in July 2024, projections from Cancer Research UK, a UK-based cancer charity, indicate that cancer incidence rates in the United Kingdom are forecasted to climb for most types between 2023-2025 and 2038-2040, with increases varying from less than 1% for breast cancer to 50% for eye cancer, whereas a fewer number of cancers are predicted to decrease, with drops from 2% for lung cancer to 27% for mesothelioma. Consequently, the growing population of cancer patients worldwide fuels the growth of the transfection reagents and equipment market.
Which Segment Categories Are Included In The Transfection Reagents And Equipment Market Segment Analysis?
The transfection reagents and equipment market covered in this report is segmented –
1) By Product: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By End User: Biopharma, Contract Research Organizations (CROs), Academia
Subsegments:
1) By Instruments: Electroporation Systems, Microinjection Systems, Particle Bombardment Systems
2) By Reagent And Kits: Lipid-Based Transfection Reagents, Polymer-Based Transfection Reagents, Protein-Based Transfection Reagents, Nucleic Acid Delivery Kits
Which Trends Are Shaping Growth In The Transfection Reagents And Equipment Market?
Leading companies in the transfection reagents and equipment market are prioritizing the development of innovative breakthroughs, such as GMP-grade AAV transfection reagents, to enhance the efficiency of viral vector production and facilitate large-scale gene therapy manufacturing. A GMP-grade AAV transfection reagent is a chemical formulation that complies with regulations, designed to enable highly efficient delivery of genetic material into suspension cell cultures for the scalable production of recombinant adeno-associated virus vectors. For instance, in July 2025, Yeasen Biotechnology, a China-based biotechnology manufacturer, obtained U.S. Food and Drug Administration Drug Master File acceptance for its UltraAAV PEI Transfection Reagent—GMP grade. This reagent demonstrates substantially higher viral titers and significantly improved full capsid ratios across multiple adeno-associated virus serotypes, providing superior performance compared to standard formulations. Furthermore, it improves manufacturing efficiency by achieving comparable vector yields with reduced reagent usage, all while adhering to the stringent regulatory and quality standards essential for clinical and commercial gene therapy production.
Who Are The Active Companies Shaping The Transfection Reagents And Equipment Market?
Major companies operating in the transfection reagents and equipment market are Thermo Fisher Scientific Inc., Promega Corporation, Qiagen N.V., Bio-Rad Laboratories Inc., MaxCyte Inc., Lonza Group Ltd., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., Altogen Biosystems, Applied Biological Materials Inc., Bex Co. Ltd., Takara Bio Inc., Polyplus-transfection SA, Sigma-Aldrich Corporation, Transfection Technologies Inc., Viromer, ABM Inc., chemicell GmbH, Genlantis, Biontech Laboratories GmbH, Jena Bioscience GmbH, PromoCell GmbH, PerkinElmer Inc., Sartorius AG, Hoffmann-La Roche Ltd., Bio-Techne Corporation, Biotium Inc., Cell Applications Inc.
Get The Full Transfection Reagents And Equipment Market Report:
Which Region Is The Top Contributor To The Transfection Reagents And Equipment Market By Share?
North America was the largest region in the transfection reagents and equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection reagents and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Transfection Reagents And Equipment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Transfection Reagents And Equipment Market 2026, By The Business Research Company
Biotechnology Reagents Market Report 2026
https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report
Sterilization Equipment And Disinfectants Market 2026
https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market
Sequencing Reagents Market Report 2026
https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model